Epidiolex Gives GW Pharmaceuticals Boost In Global Markets

GW Pharmaceuticals scored a significant victory in the United States with its cannabis-based epilepsy drug Epidiolex in mid-April. The company received approval from a U.S. Food and Drug Administration (FDA) panel for its use in treating two forms of drug-resistant epilepsy. The drug was granted “orphan drug” status in the […]

GW Pharma’s Epidiolex Gets Encouraging FDA Assessment

According to a press release, last week GW Pharmaceuticals’ drug Epidiolex received a positive FDA panel review, which is an encouraging and important step towards getting the drug approved by the U.S. Food and Drug Administration and on the market in the United States. Epidiolex is an anti-epilepsy drug, taken […]

SC Labs Santa Cruz Gets ISO 17025 Accreditation

Earlier this week, SC Labs issued a press release announcing they achieved ISO/IEC 17025:2005 accreditation for the cannabinoids panel at their Santa Cruz location. “We are thrilled to announce our ISO accreditation as this is one of our most important achievements over the past seven years of serving the cannabis […]